Literature DB >> 17264933

Synthetic non-peptide mimetics of alpha-helices.

Jessica M Davis1, Lun K Tsou, Andrew D Hamilton.   

Abstract

Proteins in nature fold into native conformations in which combinations of peripherally projected aliphatic, aromatic and ionic functionalities direct a wide range of properties. Alpha-helices, one of the most common protein secondary structures, serve as important recognition regions on protein surfaces for numerous protein-protein, protein-DNA and protein-RNA interactions. These interactions are characterized by conserved structural features within the alpha-helical domain. Rational design of structural mimetics of these domains with synthetic small molecules has proven an effective means to modulate such protein functions. In this tutorial review we discuss strategies that utilize synthetic small-molecule antagonists to selectively target essential protein-protein interactions involved in certain diseases. We also evaluate some of the protein-protein interactions that have been or are potential targets for alpha-helix mimetics.

Mesh:

Substances:

Year:  2007        PMID: 17264933     DOI: 10.1039/b608043j

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  65 in total

1.  Optically pure, water-stable metallo-helical 'flexicate' assemblies with antibiotic activity.

Authors:  Suzanne E Howson; Albert Bolhuis; Viktor Brabec; Guy J Clarkson; Jaroslav Malina; Alison Rodger; Peter Scott
Journal:  Nat Chem       Date:  2011-11-27       Impact factor: 24.427

2.  Extending foldamer design beyond α-helix mimicry: α/β-peptide inhibitors of vascular endothelial growth factor signaling.

Authors:  Holly S Haase; Kimberly J Peterson-Kaufman; Sheeny K Lan Levengood; James W Checco; William L Murphy; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2012-05-01       Impact factor: 15.419

3.  Universal peptidomimetics.

Authors:  Eunhwa Ko; Jing Liu; Lisa M Perez; Genliang Lu; Amber Schaefer; Kevin Burgess
Journal:  J Am Chem Soc       Date:  2010-12-23       Impact factor: 15.419

4.  Heterocyclic alpha-helix mimetics for targeting protein-protein interactions.

Authors:  Shannon M Biros; Lionel Moisan; Enrique Mann; Alexandre Carella; Dayong Zhai; John C Reed; Julius Rebek
Journal:  Bioorg Med Chem Lett       Date:  2007-05-27       Impact factor: 2.823

Review 5.  Knitting and untying the protein network: modulation of protein ensembles as a therapeutic strategy.

Authors:  Susana Gordo; Ernest Giralt
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

6.  Evaluating minimalist mimics by exploring key orientations on secondary structures (EKOS).

Authors:  Dongyue Xin; Eunhwa Ko; Lisa M Perez; Thomas R Ioerger; Kevin Burgess
Journal:  Org Biomol Chem       Date:  2013-10-14       Impact factor: 3.876

7.  Multicomponent synthesis of dihydrobenzoxazepinones, bearing four diversity points, as potential α-helix mimics.

Authors:  Luca Banfi; Andrea Basso; Valentina Cerulli; Giuseppe Guanti; Paulina Lecinska; Ilaria Monfardini; Renata Riva
Journal:  Mol Divers       Date:  2009-11-28       Impact factor: 2.943

8.  Synthetic alpha-helix mimetics as agonists and antagonists of islet amyloid polypeptide aggregation.

Authors:  Ishu Saraogi; James A Hebda; Jorge Becerril; Lara A Estroff; Andrew D Miranker; Andrew D Hamilton
Journal:  Angew Chem Int Ed Engl       Date:  2010       Impact factor: 15.336

9.  Exploring novel strategies for AIDS protozoal pathogens: α-helix mimetics targeting a key allosteric protein-protein interaction in C. hominis TS-DHFR.

Authors:  W Edward Martucci; Johanna M Rodriguez; Melissa A Vargo; Matthew Marr; Andrew D Hamilton; Karen S Anderson
Journal:  Medchemcomm       Date:  2013-09       Impact factor: 3.597

10.  Synthesis of biphenyl proteomimetics as estrogen receptor-alpha coactivator binding inhibitors.

Authors:  Anna B Williams; Patrick T Weiser; Robert N Hanson; Jillian R Gunther; John A Katzenellenbogen
Journal:  Org Lett       Date:  2009-12-03       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.